Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiming Lai

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Clinical and Translational Medicine|November 2, 2020
The metastatic promoter DEPDC1B induces epithelial-mesenchymal transition and promotes prostate cancer cell proliferation via Rac1-PAK1 signalingZean Li, Qiong Wang, Shirong Peng, et al.
Aging|May 28, 2020
Topoisomerase II-binding protein 1 promotes the progression of prostate cancer via ATR-CHK1 signaling pathwayKaiwen Li, Shirong Peng, Zean Li, et al.
International Journal of Biological Sciences|May 31, 2022
UBE2S as a novel ubiquitinated regulator of p16 and β-catenin to promote bone metastasis of prostate cancerShengmeng Peng, Xu Chen, Chaoyun Huang, et al.
Medcomm|February 19, 2025
Contrast-enhanced ultrasound enables precision diagnosis of preoperative muscle invasion in bladder cancer: a prospective studyQiyun Ou, Weibin Xie, Yunfang Yu, et al.
Molecular Carcinogenesis|July 22, 2014
Autophagy defects suggested by low levels of autophagy activator MAP1S and high levels of autophagy inhibitor LRPPRC predict poor prognosis of prostate cancer patientsXianhan Jiang, Weide Zhong, Hai Huang, et al.
Chinese Medical Journal|February 28, 2014
Prostate specific membrane antigen knockdown impairs the tumorigenicity of LNCaP prostate cancer cells by inhibiting the phosphatidylinositol 3-kinase/Akt signaling pathwayZhenghui Guo, Yiming Lai, Tao Du, et al.
Iscience|August 20, 2024
SERPINH1 modulates apoptosis by inhibiting P62 ubiquitination degradation to promote bone metastasis of prostate cancerChen Tang, Yiming Lai, Lingfeng Li, et al.
Cancer|January 7, 2014
Elevated levels of mitochondrion-associated autophagy inhibitor LRPPRC are associated with poor prognosis in patients with prostate cancerXianhan Jiang, Xun Li, Hai Huang, et al.
International Journal of Surgery (London, England)|June 19, 2023
Long-term survival after female pelvic organ-sparing radical cystectomy versus standard radical cystectomy: a multi-institutional propensity score-matched analysisWenlong Zhong, Kun Xia, Libo Liu, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Clinical and Translational Medicine|November 2, 2020
The metastatic promoter DEPDC1B induces epithelial-mesenchymal transition and promotes prostate cancer cell proliferation via Rac1-PAK1 signalingZean Li, Qiong Wang, Shirong Peng, et al.
Aging|May 28, 2020
Topoisomerase II-binding protein 1 promotes the progression of prostate cancer via ATR-CHK1 signaling pathwayKaiwen Li, Shirong Peng, Zean Li, et al.
International Journal of Biological Sciences|May 31, 2022
UBE2S as a novel ubiquitinated regulator of p16 and β-catenin to promote bone metastasis of prostate cancerShengmeng Peng, Xu Chen, Chaoyun Huang, et al.
Medcomm|February 19, 2025
Contrast-enhanced ultrasound enables precision diagnosis of preoperative muscle invasion in bladder cancer: a prospective studyQiyun Ou, Weibin Xie, Yunfang Yu, et al.
Molecular Carcinogenesis|July 22, 2014
Autophagy defects suggested by low levels of autophagy activator MAP1S and high levels of autophagy inhibitor LRPPRC predict poor prognosis of prostate cancer patientsXianhan Jiang, Weide Zhong, Hai Huang, et al.
Chinese Medical Journal|February 28, 2014
Prostate specific membrane antigen knockdown impairs the tumorigenicity of LNCaP prostate cancer cells by inhibiting the phosphatidylinositol 3-kinase/Akt signaling pathwayZhenghui Guo, Yiming Lai, Tao Du, et al.
Iscience|August 20, 2024
SERPINH1 modulates apoptosis by inhibiting P62 ubiquitination degradation to promote bone metastasis of prostate cancerChen Tang, Yiming Lai, Lingfeng Li, et al.
Cancer|January 7, 2014
Elevated levels of mitochondrion-associated autophagy inhibitor LRPPRC are associated with poor prognosis in patients with prostate cancerXianhan Jiang, Xun Li, Hai Huang, et al.
International Journal of Surgery (London, England)|June 19, 2023
Long-term survival after female pelvic organ-sparing radical cystectomy versus standard radical cystectomy: a multi-institutional propensity score-matched analysisWenlong Zhong, Kun Xia, Libo Liu, et al.
Pageof 6